SUBSCRIBE TO OUR NEWSLETTER

Sign-up now to stay on top of what’s new at Laserderm, be the first to hear about our promotions, and get the best skincare tips and tricks in the industry.

About Dr. MacIsaac

drmacweb

Jennifer MacIsaac received her MD from the University of Toronto in 2006. She completed her Family Medicine residency with specialized training in Skin Conditions and Women’s Health through the University of Ottawa. Her Women’s Health Fellowship included managing focused gynecologic conditions, as well as more broad, hormonally-related symptoms. She was an Assistant professor, lecturer and clinical supervisor for the University of Ottawa throughout her Family Medicine Practice. She then completed her Dermatology residency with the University of Ottawa, followed by a Fellowship Year in Cutaneous Laser Surgery and Cosmetic Dermatology at Laserderm. Dr. MacIsaac is a double board-certified Dermatologist since 2014 (Royal College of Physicians and Surgeons in Canada and the American Board of Dermatology in the US).

Dr. MacIsaac joined Laserderm after the completion of her fellowship training, and is fully immersed in all aspects of laser surgery and cosmetic dermatology. She continues her teaching and clinical supervising activities for the University of Ottawa in Dermatology. She supervises the Women’s Health program at Laserderm, which focuses on laser and non-surgical solutions for common pelvic disorders such as urinary incontinence, vaginal atrophy, and sexual dysfunction.

 

Professional Associations                                                                       

Royal College of Physicians and Surgeons of Canada

American Board of Dermatology

College of Family Physicians of Canada

College of Physicians and Surgeons of Ontario

Canadian Dermatology Association

Canadian Medical Association

Ontario Medical Association

 

Publications and Presentations                                                     

Andrew P, Valiani S, MacIsaac J, Mithoowani H, Verma S. (2014) Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review. Breast Cancer Res Treat 148(1): 1-5.

MacIsaac JL, Ward C, Pratt M. (2013) Cutaneous T-cell lymphoma-like drug eruption in an HIV-positive patient taking vancomycin and rifampin. JCMS 17(6): 433-6.

 

MacIsaac JL, Heughan C, Ward C, Weatherhead L. Rate of metastatic malignant melanoma in sentinel node negative patients: The Ottawa Experience. Presented at the Canadian Dermatology Association 87th Annual Conference. July 2013. Ottawa, ON.

MacIsaac JL, Fahim S, Gill J. Case of delayed eosinophilic, polymorphic, and pruritic eruption associated with radiotherapy (EPPER) mimicking Langerhans cell histiocytosis in a patient with non-Hodgkin’s lymphoma and review of the literature. Presented at the Canadian Dermatology Association 87th Annual Conference. July 2013. Ottawa, ON.

MacIsaac JL, Heughan C, Ward C, Weatherhead L. Rate of metastatic malignant melanoma in sentinel node negative patients: The Ottawa Experience. Presented at the Canadian Melanoma Conference. February 2013. Banff, AB.

MacIsaac J, Rosenberg, H, Kuling P. The Impact of the Half-Day Back: Is the Half-Day Back Meeting the Needs of Family Medicine Residents? Presented at Family Medicine Research Day. June 2008.

MacIsaac J. (2005) Quick Diagnosis: Case Reports from the University of Toronto Faculty of Medicine. UTMJ 82(3): 193.

MacIsaac J. “Pneumonia in Children” Chapter Editor In:  Evans MF, editor. Mosby’s Family Practice Sourcebook: An Evidence-Based Approach to Care. 4th edition. Toronto: Elsevier Mosby, 2005.

MacIsaac J, Masih RJ, Smith D. Sudbury Regional Hospital Quality Control Evaluation – Hospitalist Service. Presented at The Sudbury Regional Hospital Quality Control Meeting. Aug 2003.

 

Ongoing Research

MacIsaac JL, Heughan C, Ward C, Weatherhead L. Rate of metastatic malignant melanoma in sentinel node negative patients: The Ottawa Experience. Manuscript in preparation

Ward C, MacIsaac JL, Bradshaw S, Heughan C, Weatherhead, L. False negative rate of sentinel lymph node detection of metastatic melanoma: The Ottawa Experience. Research ongoing

Top